SarS-CoV-2 vaccines and biological treatments: dermatological perspectives

被引：4
|
作者：
Stingeni, Luca [1 ]
Bianchi, Leonardo [1 ]
Peris, Ketty [2 ]
Fabbrocini, Gabriella [3 ]
Micali, Giuseppe [4 ]
Calzavara-Pinton, Piergiacomo [5 ]
Tramontana, Marta [1 ]
Hansel, Katharina [1 ]
机构：
[1] Univ Perugia, Dermatol Sect, Dept Med & Surg, Perugia, Italy
[2] Sacred Heart Catholic Univ, Dermatol Sect, Dept Translat Med & Surg, Rome, Italy
[3] Univ Naples Federico II, Dept Dermatol, Naples, Italy
[4] Univ Catania, Dermatol Clin, Catania, Italy
[5] Univ Brescia, Dept Dermatol, ASSt Spedali Civili Brescia, Brescia, Italy
来源：
ITALIAN JOURNAL OF DERMATOLOGY AND VENEREOLOGY | 2021年 / 156卷 / 02期
关键词：
D O I：
10.23736/S2784-8671.21.07055-9
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：118 / 120
页数：3
相关论文
共 50 条
  • [41] SARS-CoV-2 vaccines and donor recruitment for FMT
    Ianiro, Gianluca
    Mullish, Benjamin H.
    Hvas, Christian Lodberg
    Segal, Jonathan P.
    Kuijper, Ed J.
    Costello, Samuel P.
    Kelly, Colleen R.
    Allegretti, Jessica R.
    Fischer, Monika
    Iqbal, Tariq H.
    Satokari, Reetta
    Kao, Dina
    van Prehn, Joffrey
    Ng, Siew C.
    Bibbo, Stefano
    Baunwall, Simon Mark Dahl
    Quraishi, Mohammed N.
    Sokol, Harry
    Zhang, Faming
    Keller, Josbert
    Masucci, Luca
    Quaranta, Gianluca
    Kassam, Zain
    Sanguinetti, Maurizio
    Tilg, Herbert
    Gasbarrini, Antonio
    Cammarota, Giovanni
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2021, 6 (04): : 264 - 266
  • [42] The success of SARS-CoV-2 vaccines and challenges ahead
    Subbarao, Kanta
    CELL HOST & MICROBE, 2021, 29 (07) : 1111 - 1123
  • [43] Neurological Adverse Reactions to SARS-CoV-2 Vaccines
    Finsterer, Josef
    CLINICAL PSYCHOPHARMACOLOGY AND NEUROSCIENCE, 2023, 21 (02) : 222 - 239
  • [44] Impact of SARS-CoV-2 vaccines on the nervous system
    Scorza, Fulvio Alexandre
    Finsterer, Josef
    CLINICAL IMAGING, 2022, 82 : 13 - 14
  • [45] Timely development of vaccines against SARS-CoV-2
    Lu, Shan
    EMERGING MICROBES & INFECTIONS, 2020, 9 (01) : 542 - 544
  • [46] SARS-CoV-2 evolution and vaccines: cause for concern?
    Williams, Thomas C.
    Burgers, Wendy A.
    LANCET RESPIRATORY MEDICINE, 2021, 9 (04): : 333 - 335
  • [47] Advances in the design and development of SARS-CoV-2 vaccines
    Peng, Xue-Liang
    Cheng, Ji-Si-Yu
    Gong, Hai-Lun
    Yuan, Meng-Di
    Zhao, Xiao-Hong
    Li, Zibiao
    Wei, Dai-Xu
    MILITARY MEDICAL RESEARCH, 2021, 8 (01)
  • [48] Ensuring Uptake of Vaccines against SARS-CoV-2
    Mello, Michelle M.
    Silverman, Ross D.
    Omer, Saad B.
    NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (14): : 1296 - 1299
  • [49] Impact of SARS-CoV-2 variants on mRNA vaccines
    Venkatesan, Priya
    LANCET MICROBE, 2021, 2 (09): : E428 - E428
  • [50] SARS-CoV-2 Vaccines: Where Are We Now?
    Flanagan, Katie L.
    MacIntyre, C. Raina
    McIntyre, Peter B.
    Nelson, Michael R.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2021, 9 (10): : 3535 - 3543
12345